Salmon-Ceron D - Search Results

1

[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].

Lesueur A, Fillet AM, Bouscary D, Ginsburg C, Palmer P, Chaine B, Salmon-Ceron D, Dreyfus F, Huraux JM, Sicard D. Lesueur A, et al. Ann Dermatol Venereol. 1998 Feb;125(2):127-8. Ann Dermatol Venereol. 1998. PMID: 9747231 French.

2

[Characteristics of rapid progressors in HIV infection].

Khanlou H, Salmon-Ceron D, Sicard D. Khanlou H, et al. Ann Med Interne (Paris). 1997;148(2):163-6. Ann Med Interne (Paris). 1997. PMID: 9238442 Review. French.

3

[Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].

Salmon-Céron D, Deleuze J, Coste J, Guerin C, Ginsburg C, Blanche P, Finkielsztejn L, Pecqueux L, Chaput S, Gorin I, Sicard D. Salmon-Céron D, et al. Ann Med Interne (Paris). 2000 Jun;151(4):297-302. Ann Med Interne (Paris). 2000. PMID: 10922958 French.

4

[Search for a HIV vaccine].

Sicard D, Salmon-Ceron D, Finkielsztejn L. Sicard D, et al. Presse Med. 1997 Feb 22;26(5):248-54. Presse Med. 1997. PMID: 9122120 Review. French.

5

Muscular bacillary angiomatosis in AIDS.

Blanche P, Bachmeyer C, Salmon-Céron D, Sicard D. Blanche P, et al. J Infect. 1998 Sep;37(2):193. doi: 10.1016/s0163-4453(98)80179-5. J Infect. 1998. PMID: 9821099

6

Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.

Salmon-Céron D, Fillet AM, Aboulker JP, Gérard L, Houhou N, Carrière I, Ostinelli J, Vildé JL, Brun-Vézinet F, Leport C. Salmon-Céron D, et al. Clin Infect Dis. 1999 Apr;28(4):901-5. doi: 10.1086/515223. Clin Infect Dis. 1999. PMID: 10825058 Clinical Trial.

7

Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection.

De La Blanchardiere A, Rozenberg F, Caumes E, Picard O, Lionnet F, Livartowski J, Coste J, Sicard D, Lebon P, Salmon-Cèron D. De La Blanchardiere A, et al. Scand J Infect Dis. 2000;32(3):263-9. doi: 10.1080/00365540050165893. Scand J Infect Dis. 2000. PMID: 10879596

8

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D. Salmon-Céron D, et al. AIDS. 2000 May 26;14(8):1041-9. doi: 10.1097/00002030-200005260-00017. AIDS. 2000. PMID: 10853987 Clinical Trial.

9

[Prevalence and risk factors of hepatitis A infection in an HIV-infected French population].

Brunet A, Grabar S, Blanche P, Héripret-Fredouille L, Spiridon G, Calboreanu A, Rollot F, Launay O, Sicard D, Salmon-Céron D, Abad S. Brunet A, et al. Med Mal Infect. 2005 Feb;35(2):73-81. doi: 10.1016/j.medmal.2004.09.006. Med Mal Infect. 2005. PMID: 15780896 French.

10

[Aspergillus niger osteitis of the middle ear in a patient with HIV infection].

Lesueur A, Salmon Ceron D, Corlieu P, Ginsburg C, Sicard D. Lesueur A, et al. Presse Med. 1997 Jul 5;26(23):1098. Presse Med. 1997. PMID: 9246102 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters